210 related articles for article (PubMed ID: 29596531)
21. Crystal structures of APOBEC3G N-domain alone and its complex with DNA.
Xiao X; Li SX; Yang H; Chen XS
Nat Commun; 2016 Aug; 7():12193. PubMed ID: 27480941
[TBL] [Abstract][Full Text] [Related]
22. Nanoscale structure and dynamics of ABOBEC3G complexes with single-stranded DNA.
Shlyakhtenko LS; Lushnikov AY; Miyagi A; Li M; Harris RS; Lyubchenko YL
Biochemistry; 2012 Aug; 51(32):6432-40. PubMed ID: 22809226
[TBL] [Abstract][Full Text] [Related]
23. Replication protein A (RPA) hampers the processive action of APOBEC3G cytosine deaminase on single-stranded DNA.
Lada AG; Waisertreiger IS; Grabow CE; Prakash A; Borgstahl GE; Rogozin IB; Pavlov YI
PLoS One; 2011; 6(9):e24848. PubMed ID: 21935481
[TBL] [Abstract][Full Text] [Related]
24. Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s.
Hou S; Lee JM; Myint W; Matsuo H; Kurt Yilmaz N; Schiffer CA
J Biol Chem; 2021 Aug; 297(2):100909. PubMed ID: 34171358
[TBL] [Abstract][Full Text] [Related]
25. Structural Investigations on the Interactions between Cytidine Deaminase Human APOBEC3G and DNA.
Yan X; Lan W; Wang C; Cao C
Chem Asian J; 2019 Jul; 14(13):2235-2241. PubMed ID: 31116511
[TBL] [Abstract][Full Text] [Related]
26. APOBEC3G cytosine deamination hotspots are defined by both sequence context and single-stranded DNA secondary structure.
Holtz CM; Sadler HA; Mansky LM
Nucleic Acids Res; 2013 Jul; 41(12):6139-48. PubMed ID: 23620282
[TBL] [Abstract][Full Text] [Related]
27. Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.
He Z; Zhang W; Chen G; Xu R; Yu XF
J Mol Biol; 2008 Sep; 381(4):1000-11. PubMed ID: 18619467
[TBL] [Abstract][Full Text] [Related]
28. Structural Determinants of the APOBEC3G N-Terminal Domain for HIV-1 RNA Association.
Fukuda H; Li S; Sardo L; Smith JL; Yamashita K; Sarca AD; Shirakawa K; Standley DM; Takaori-Kondo A; Izumi T
Front Cell Infect Microbiol; 2019; 9():129. PubMed ID: 31165049
[TBL] [Abstract][Full Text] [Related]
29. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
[TBL] [Abstract][Full Text] [Related]
30. APOBEC3A Loop 1 Is a Determinant for Single-Stranded DNA Binding and Deamination.
Ziegler SJ; Hu Y; Devarkar SC; Xiong Y
Biochemistry; 2019 Sep; 58(37):3838-3847. PubMed ID: 31448897
[TBL] [Abstract][Full Text] [Related]
31. RNA-binding residues in the N-terminus of APOBEC3G influence its DNA sequence specificity and retrovirus restriction efficiency.
BĂ©langer K; Langlois MA
Virology; 2015 Sep; 483():141-8. PubMed ID: 25974865
[TBL] [Abstract][Full Text] [Related]
32. Dimerization regulates both deaminase-dependent and deaminase-independent HIV-1 restriction by APOBEC3G.
Morse M; Huo R; Feng Y; Rouzina I; Chelico L; Williams MC
Nat Commun; 2017 Sep; 8(1):597. PubMed ID: 28928403
[TBL] [Abstract][Full Text] [Related]
33. Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface.
Letko M; Booiman T; Kootstra N; Simon V; Ooms M
Cell Rep; 2015 Dec; 13(9):1789-99. PubMed ID: 26628364
[TBL] [Abstract][Full Text] [Related]
34. Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA.
Maiti A; Myint W; Kanai T; Delviks-Frankenberry K; Sierra Rodriguez C; Pathak VK; Schiffer CA; Matsuo H
Nat Commun; 2018 Jun; 9(1):2460. PubMed ID: 29941968
[TBL] [Abstract][Full Text] [Related]
35. APOBEC3s: DNA-editing human cytidine deaminases.
Silvas TV; Schiffer CA
Protein Sci; 2019 Sep; 28(9):1552-1566. PubMed ID: 31241202
[TBL] [Abstract][Full Text] [Related]
36. A DNA sequence recognition loop on APOBEC3A controls substrate specificity.
Logue EC; Bloch N; Dhuey E; Zhang R; Cao P; Herate C; Chauveau L; Hubbard SR; Landau NR
PLoS One; 2014; 9(5):e97062. PubMed ID: 24827831
[TBL] [Abstract][Full Text] [Related]
37. APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element.
Nowarski R; Prabhu P; Kenig E; Smith Y; Britan-Rosich E; Kotler M
J Mol Biol; 2014 Jul; 426(15):2840-53. PubMed ID: 24859335
[TBL] [Abstract][Full Text] [Related]
38. Small-Angle X-ray Scattering (SAXS) Measurements of APOBEC3G Provide Structural Basis for Binding of Single-Stranded DNA and Processivity.
Barzak FM; Ryan TM; Mohammadzadeh N; Harjes S; Kvach MV; Kurup HM; Krause KL; Chelico L; Filichev VV; Harjes E; Jameson GB
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146779
[TBL] [Abstract][Full Text] [Related]
39. Long-term passage of Vif-null HIV-1 in CD4
Miyagi E; Kao S; Fumitaka M; Buckler-White A; Plishka R; Strebel K
Virology; 2017 Apr; 504():1-11. PubMed ID: 28131088
[TBL] [Abstract][Full Text] [Related]
40. APOBEC3G is a restriction factor of EV71 and mediator of IMB-Z antiviral activity.
Wang H; Zhong M; Li Y; Li K; Wu S; Guo T; Cen S; Jiang J; Li Z; Li Y
Antiviral Res; 2019 May; 165():23-33. PubMed ID: 30862444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]